Effects of gadolinium-based contrast agents on submandibular gland tissue in rats

  • Fatma Beyazal Celiker
  • Levent Tumkaya
  • Adnan Yilmaz
  • Zerrin Ozergin Coskun
  • Metin Celiker
  • Fatih Oghan
  • Tolga Mercantepe
  • Suat Terzi
  • Engin Dursun
Miscellaneous

Abstract

Aim

The aim of this prospective animal study is to investigate the influence of multiple administrations of macrocyclic ionic (gadoteric acid) and linear nonionic (gadodiamide) gadolinium-based contrast agents (GBCA) on submandibular gland tissue (SGT) of the rats.

Material and method

Twenty-four Sprague Dawley female rats were included the study. Group 1 was determined as a control group (n = 6). Group 2 was determined as saline group (n = 6). Group 3 was determined as Omniscan group (n = 6) and received only intraperitoneal (IP) 0.1 mmol (0.2 mL/kg)/kg gadodiamide for 8 days. Group 4 was determined as Dotarem group (n = 6) and received only IP 0.1 mmol (0.2 mL/kg)/mg/kg gadoteric acid daily for 8 days. On the 9th day of the administration, the rats were sedated with ketamine and xylazine through IP injection. The right SGT was removed after sedation. Histopathological and immunohistochemical changes in SGT were evaluated.

Results

The SGT of the Omniscan and Dotarem groups decreased SGT acini surface area, and serous acinar cells number were observed. On the other hand, no pathology was observed. Mucous acinar cells’ caspase-3 positivity for the same markers in Omniscan and Dotarem sections was similar to the control group. However, Omniscan and Dotarem groups serous acinar cells were caspase-3 (+) staining. The intensity of serous acinar cells’ caspase-3 (+) for the same markers in Dotarem sections was similar to the Omniscan group. The results also revealed in the analysis of the mean area of the acinus area of the SGT; there were significantly decreased Dotarem group rats when compared to control rats (p < 0.05).

Conclusion

We consider that numerical increased apoptosis results arise from repeated doses of GBCAs. Being aware of this effect of the contrast agent may have significance for the chronic sialo-adenitis patients group when used for recurrent contrasted MRI for diagnosis of diseases like MS which requires in follow-up. We should be aware about the frequently contrasted MRI in routine investigations.

Keywords

Gadolinium Submandibular gland Contrast Rat 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Research involving human participants and/or animals

This research involving animals was approved by Animal Ethical Committee with the number of 2016/7. All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted.

Informed consent

Animal welfares were obtained.

References

  1. 1.
    Kanal E, Maravilla K, Rowley HA (2014) Gadoliniumcontrastagentsfor CNSimaging: current concepts and clinical evidence. AJNR Am J Neuroradiol 35:2215–2226CrossRefPubMedGoogle Scholar
  2. 2.
    Sherry AD, Caravan P, Lenkinski RE (2009) Primer on gadolinium chemistry. J Magn Reson Imaging 30(6):1240–1248CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Bellin MF, Vasile M, Morel_ Precetti S (2003) Currently used nonspecific extracellular MR contrast media. Eur Radiol 13:2688 – 698CrossRefPubMedGoogle Scholar
  4. 4.
    Caravan P, Ellison JJ, McMurry TJ et al (1999) Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications. Chem Rev 99:2293–2352CrossRefPubMedGoogle Scholar
  5. 5.
    Grobner T (2006) Gadolinium—a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 21:1104–1108CrossRefPubMedGoogle Scholar
  6. 6.
    Frenzel T, Lengsfeld P, Schirmer H et al (2008) Stability of gadolinium-based magnetic resonance imaging contrast agents in human serum at 37 °C. Invest Radiol 43:817–828CrossRefPubMedGoogle Scholar
  7. 7.
    KandaT IshiiK (2014) KawaguchiH, et al. Highsignalintensityinthedentatenucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material. Radiology 270:834–841CrossRefGoogle Scholar
  8. 8.
    ErranteY CirimeleV (2014) MallioCA, et al. Progressive increase of T1signalintensity of the dentate nucleus on unenhanced magnetic resonance images is associated with cumulative doses of intravenously administered gadodiamide in patients with normal renal function, suggesting dechelation. Invest Radiol 49:685–690CrossRefGoogle Scholar
  9. 9.
    Kanda T, Osawa M, Oba H et al (2015) High signal intensity in dentate nucleus on unenhanced T1-weighted MR images: association with linear versus macrocyclic gadolinium chelate administration. Radiology 275:800–809CrossRefGoogle Scholar
  10. 10.
    Quattrocchi CC, Mallio CA, Errante Y et al (2015) Gadodiamide and dentate nucleus T1 hyperintensity in patients with meningioma evaluated by multiple follow-up contrast-enhanced magnetic resonance examinations with no systemic interval therapy. Invest Radiol 50:470–472CrossRefPubMedGoogle Scholar
  11. 11.
    McDonald RJ, McDonald JS, Kallmes DF et al (2015) Intracranial gadolinium deposition after contrast-enhanced MR imaging. Radiology 275:772–782CrossRefPubMedGoogle Scholar
  12. 12.
    Haylor J, Schroeder J, Wagner B, Nutter F, Jestin G, Idée JM, Morcos S (2012) Skin gadolinium following use of MR contrast agents in a rat model of nephrogenic systemic fibrosis. Radiology 263:107–16CrossRefPubMedGoogle Scholar
  13. 13.
    Haylor J, Dencausse A, Vickers M, Nutter F, Jestin G, Slater D, Idee JM, Morcos S (2010) Nephrogenic gadolinium biodistribution and skin cellularity following a single injection of Omniscan in the rat. Invest Radiol 45:507–12CrossRefPubMedGoogle Scholar
  14. 14.
    Kanda T, Fukusato T, Matsuda M et al (2015) Gadolinium-based contrast agent accumulates in the brain even in subjects without severe renal dysfunction: evaluation of autopsy brain specimens with inductively coupled plasma mass spectroscopy. Radiology 276:228–32CrossRefPubMedGoogle Scholar
  15. 15.
    Murata N, Murata K, Gonzalez-Cuyar LF, Maravilla KR (2016) Gadolinium tissue deposition in brain and bone. Magn Reson Imaging 34(10):1359–1365CrossRefPubMedGoogle Scholar
  16. 16.
    Roberts DR, Lindhorst SM, Welsh CT et al (2016) High levels of gadolinium deposition in the skin of a patient with normal renal function. Invest Radiol 51(5):280–289PubMedGoogle Scholar
  17. 17.
    Wáng YX, Schroeder J, Siegmund H, Idée JM, Fretellier N, Jestin-Mayer G, Factor C, Deng M, Kang W, Morcos SK (2015) Totalgadolanium tissue deposition and skin structural findings following the administration of structurally different gadolinium chelates in healthy and ovariectomized female rats. Quant Imaging Med Surg 5(4):534–45PubMedPubMedCentralGoogle Scholar
  18. 18.
    Kanal E, Tweedle MF (2015) Residual or retained gadolinium: practical implications for radiologists and our patients. Radiology 275(3):630–634CrossRefPubMedGoogle Scholar
  19. 19.
    Tedeschi E, Palma G, Canna A et al (2016) In vivo dentate nucleus MRI relaxometry correlates with previous administration of gadolinium-based contrast agents. Eur Radiol 26(12):4577–4584CrossRefPubMedGoogle Scholar
  20. 20.
    Fasano M, Curry S, Terreno E et al (2005) The extraordinary ligand binding properties of human serum albumin. IUBMB Life 57(12):787–796CrossRefPubMedGoogle Scholar
  21. 21.
    Aime S, Caravan P (2009) Biodistribution of gadolinium-based contrast agents, including gadolinium deposition. J Magn Reson Imaging 30(6):1259–1267CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Gou BD, Bian S, Zhang TL, Wang K (2010) Gadolinium-promoted precipitation of calcium phosphate is associated with profibrotic activation of RAW 264.7 macrophages. Toxicol In Vitro 24(6):1743–1749CrossRefPubMedGoogle Scholar
  23. 23.
    Tumkaya L, Kalkan Y, Bas O, Yilmaz A (2016) Mobile phone radiation during pubertal development has no effect on testicular histology in rats. Toxicol Ind Health 32:328–36CrossRefPubMedGoogle Scholar
  24. 24.
    Said TM, Paasch U, Glander HJ et al (2004) Role of caspases in male infertility. Hum Reprod Update 10:39–51CrossRefPubMedGoogle Scholar
  25. 25.
    Radbruch A, Weberling LD, Kieslich PJ et al (2015) Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent. Radiology 275(3):783–91CrossRefPubMedGoogle Scholar
  26. 26.
    Robert P, Lehericy S, Grand S et al (2015) T1-weighted hypersignal in the deep cerebellar nuclei after repeated administrations of gadolinium-based contrast agents in healthy rats: difference between linear and macrocyclic agents. Invest Radiol 50(8):473–80CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Pattanayak P, Santhanam P, Javadi MS, Solnes LB, Rowe SP (2017) Unilateral submandibular gland atrophy and sialolithiasis diagnosed on 99mTc-MIBI SPECT/CT in a patient with primary hyperparathyroidism. Clin Nucl Med 42(12):939–940CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Fatma Beyazal Celiker
    • 1
  • Levent Tumkaya
    • 2
  • Adnan Yilmaz
    • 3
  • Zerrin Ozergin Coskun
    • 4
  • Metin Celiker
    • 4
  • Fatih Oghan
    • 5
  • Tolga Mercantepe
    • 2
  • Suat Terzi
    • 4
  • Engin Dursun
    • 4
  1. 1.Department of Radiology, Faculty of MedicineRecep Tayyip Erdogan UniversityRizeTurkey
  2. 2.Department of Histology-Embriology, Faculty of MedicineRecep Tayyip Erdogan UniversityRizeTurkey
  3. 3.Department of Biochemistry, Faculty of MedicineRecep Tayyip Erdogan UniversityRizeTurkey
  4. 4.Department of Otorhinolaryngology, Faculty of MedicineRecep Tayyip Erdogan UniversityRizeTurkey
  5. 5.Department of ORL & HNS, Faculty of MedicineDumlupinar UniversityKutahyaTurkey

Personalised recommendations